The potential contribution of circulating and locally produced leptin to cardiac hypertrophy and failure1

Canadian Journal of Physiology and Pharmacology

Volumn 91, Issue 11, 2013, Pages 883-888

  Karmazyn, Morris ^a   Gan, Xiaohong Tracey ^a   Rajapurohitam, Venkatesh ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

Adiponectin; Cardiac hypertrophy and failure; Leptin; Mitochondria; RhoA ROCK pathway

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ANGIOTENSIN II; CALCINEURIN; CASPASE 3; ENDOTHELIN 1; JANUS KINASE 2; LEPTIN; LEPTIN RECEPTOR; REACTIVE OXYGEN METABOLITE; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SODIUM ION; STAT3 PROTEIN; TRANSCRIPTION FACTOR NFAT3;

ACTIN POLYMERIZATION; ADIPOCYTE; ADIPOGENESIS; BODY MASS; CALCIUM CELL LEVEL; CALORIC INTAKE; DEPHOSPHORYLATION; DIASTOLIC HEART FAILURE; DISEASE ASSOCIATION; DNA METHYLATION; FAT MASS; GENETIC VARIABILITY; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HORMONE SYNTHESIS; HUMAN; HYPERLEPTINEMIA; LACTOBACILLUS PLANTARUM; MITOCHONDRION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; WHITE ADIPOSE TISSUE;

ADIPONECTIN; ANIMALS; BODY COMPOSITION; CALCINEURIN; CARDIOMEGALY; HEART FAILURE; HUMANS; LEPTIN; MITOCHONDRIA, HEART; PROBIOTICS; PROTEINS; RECEPTORS, LEPTIN; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 84885445249     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2013-0057     Document Type: Review

References (80)

1. Abd El-Aziz, T.A., Mohamed, R.H., Mohamed, R.H., and Pasha, H.F. 2012. Leptin, leptin gene and leptin receptor gene polymorphism in heart failure with preserved ejection fraction. Heart Vessels, 27: 271-279. doi:10.1007/s00380-011-0152-2. PMID:21584748.
2. Abe, Y., Ono, K., Kawamura, T., Wada, H., Kita, T., Shimatsu, A., et al. 2007. Leptin induces elongation of cardiac myocytes and causes eccentric left ventricular dilatation with compensation. Am. J. Physiol. Heart Circ. Physiol. 292: H2387-H2396. doi:10.1152/ajpheart.00579.2006. PMID:17220191.
3. Ahima, R.S., and Osei, S.Y. 2004. Leptin signaling. Physiol. Behav. 81: 223-241. doi:10.1016/j.physbeh.2004.02.014. PMID:15159169.
4. Akasaka, Y., Tsunoda, M., Ogata, T., Ide, T., and Murakami, K. 2010. Direct evidence for leptin-induced lipid oxidation independent of long-form leptin receptor. Biochim. Biophys. Acta, 1801: 1115-1122. doi:10.1016/j.bbalip.2010. 06.009. PMID:20601111.
5. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257: 79-83. doi:10.1006/bbrc.1999.0255. PMID:10092513.
6. Barouch, L.A., Berkowitz, D.E., Harrison, R.W., O'Donnell, C.P., and Hare, J.M. 2003. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation, 108: 754-759. doi:10.1161/01.CIR.0000083716.82622.FD. PMID:12885755.
7. Barton, M., Carmona, R., Ortmann, J., Krieger, J.E., and Traupe, T. 2003. Obesityassociated activation of angiotensin and endothelin in the cardiovascular system. Int. J. Biochem. Cell Biol. 35: 826-837. doi:10.1016/S1357-2725(02) 00307-2. PMID:12676169.
8. Bjorbaek, C., Uotani, S., da Silva, B., and Flier, J.S. 1997. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem. 272: 32686-32695. doi:10.1074/jbc.272.51.32686. PMID:9405487.
9. Deswal, A. 2011. Obesity, leptin, and incident heart failure. J. Am. Coll. Cardiol. 58: 1878-1880. doi:10.1016/j.jacc.2011.07.030. PMID:22018298.
10. Dina, C., Meyre, D., Gallina, S., Durand, E., Korner, A., Jacobson, P., et al. 2007. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat. Genet. 39: 724-726. doi:10.1038/ng2048. PMID:17496892.
11. Doehner, W., Rauchhaus, M., Godsland, I.F., Egerer, K., Niebauer, J., Sharma, R., et al. 2002. Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. Int. J. Cardiol. 83: 73-81. doi:10.1016/S0167-5273(02)00022-0. PMID:11959387.
12. Filippatos, G.S., Tsilias, K., Venetsanou, K., Karambinos, E., Manolatos, D., Kranidis, A., et al. 2000. Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-α system. Int. J. Cardiol. 76: 117-122. doi:10.1016/S0167-5273(00)00397-1. PMID:11104865.
13. Fischer, J., Koch, L., Emmerling, C., Vierkotten, J., Peters, T., Bruning, J.C., and Ruther, U. 2009. Inactivation of the Fto gene protects from obesity. Nature, 458: 894-898. doi:10.1038/nature07848. PMID:19234441.
14. Frayling, T.M., Timpson, N.J., Weedon, M.N., Zeggini, E., Freathy, R.M., Lindgren, C.M., et al. 2007. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 316: 889-894. doi:10.1126/science.1141634. PMID:17434869.
15. Fredriksson, R., Hagglund, M., Olszewski, P.K., Stephansson, O., Jacobsson, J.A., et al. 2008. The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology, 149: 2062-2071. doi:10.1210/en.2007-1457. PMID: 18218688.
16. Fukui, A., Takahashi, N., Nakada, C., Masaki, T., Kume, O., Shinohara, T., et al. 2013. Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation. Circ. Arrhythm. Electrophysiol. 6: 402-409. doi:10.1161/CIRCEP.111.000104. PMID:23406575.
17. Gan, X.T., Zhao, G., Huang, C.X., Rowe, A.C., Purdham, D.M., and Karmazyn, M. 2013. Identification of fat mass and obesity associated (FTO) protein expression in cardiomyocytes: regulation by leptin and its contribution to leptininduced hypertrophy. PLoS One. [In press]
18. Ge, H., Huang, L., Pourbahrami, T., and Li, C. 2002. Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo. J. Biol. Chem. 277: 45898-45903. doi:10.1074/jbc.M205825200. PMID:12270921.
19. Gerken, T., Girard, C.A., Tung, Y.C., Webby, C.J., Saudek, V., Hewitson, K.S., et al. 2007. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science, 318: 1469-1472. doi:10.1126/science. 1151710. PMID:17991826.
20. Gupta, S., Drazner, M.H., and de Lemos, J.A. 2009. Newer biomarkers in heart failure. Heart Fail. Clin. 5: 579-588. doi:10.1016/j.hfc.2009.04.004. PMID: 19631181.
21. Hegyi, K., Fulop, K., Kovacs, K., Toth, S., and Falus, A. 2004. Leptin-induced signal transduction pathways. Cell Biol. Int. 28: 159-169. doi:10.1016/j.cellbi.2003.12. 003. PMID:14984741.
22. Heineke, J., and Molkentin, J.D. 2006. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7: 589-600. doi:10. 1038/nrm1983. PMID:16936699.
23. Karmazyn, M., Purdham, D.M., Rapurohitam, V., and Zeidan, A. 2008. Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovasc. Res. 79: 279-286. doi:10.1093/cvr/cvn115. PMID:18474523.
24. Kojima, S., Funahashi, T., Sakamoto, T., Miyamoto, S., Soejima, H., Hokamaki, J., et al. 2003. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart, 89: 667. doi:10.1136/heart.89.6.667. PMID:12748233.
25. Lam, V., Su, J., Koprowski, S., Hsu, A., Tweddell, J.S., Rafiee, P., et al. 2012. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 26: 1727-1735. doi:10.1096/fj.11-197921. PMID:22247331.
26. Larder, R., Cheung, M.K., Tung, Y.C., Yeo, G.S., and Coll, A.P. 2011. Where to go with FTO? Trends Endocrinol. Metab. 22: 53-59. doi:10.1016/j.tem.2010.11.001. PMID:21131211.
27. Lee, G.H., Proenca, R., Montez, J.M., Carroll, K.M., Darvishzadeh, J.G., Lee, J.I., et al. 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature, 379: 632-635. doi:10.1038/379632a0. PMID:8628397.
28. Lieb, W., Sullivan, L.M., Harris, T.B., Roubenoff, R., Benjamin, E.J., Levy, D., et al. 2009. Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals. Diabetes Care, 32: 612-616. doi:10.2337/dc08-1596. PMID:19114611.
29. Loirand, G., Guerin, P., and Pacaud, P. 2006. Rho kinases in cardiovascular physiology and pathophysiology. Circ. Res. 98: 322-334. doi:10.1161/01.RES. 0000201960.04223.3c. PMID:16484628.
30. Lollmann, B., Gruninger, S., Stricker-Krongrad, A., and Chiesi, M. 1997. Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and, e in different mouse tissues. Biochem. Biophys. Res. Commun. 238: 648-652. doi:10.1006/bbrc.1997.7205. PMID:9299568.
31. Maamra, M., Bidlingmaier, M., Postel-Vinay, M.C., Wu, Z., Strasburger, C.J., and Ross, R.J. 2002. Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors. Endocrinology, 142: 4389-4393. doi:10.1210/en.142.10.4389. PMID:11564702.
32. Madani, S., De Girolamo, S., Munoz, D.M., Li, R.K., and Sweeney, G. 2006. Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. Cardiovasc. Res. 69: 716-275. doi:10.1016/j. cardiores.2005.11.022. PMID:16376323.
33. Maffei, M., Halaas, J., Ravussin, E., Pratley, R.E., Lee, G.H., Zhang, Y., et al. 1995. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1: 1155-1161. doi:10.1038/nm1195-1155. PMID:7584987.
34. Martinez-Abundis, E., Rajapurohitam, V., Haist, J.V., Gan, X.T., and Karmazyn, M. 2012. The obesity-related peptide leptin sensitizes cardiac mitochondria to calcium-induced permeability transition pore opening and apoptosis. PLoS One, 7: e41612. doi:10.1371/journal.pone.0041612. PMID:22848545.
35. Matsui, H., Yokoyama, T., Tanaka, C., Sunaga, H., Koitabashi, N., Takizawa, T., et al. 2012. Pressure mediated hypertrophy and mechanical stretch upregulate expression of the long form of leptin receptor (ob-Rb) in rat cardiac myocytes. BMC Cell Biol. 13: 37. doi:10.1186/1471-2121-13-37. PMID:23270329.
36. McGaffin, K.R., Witham, W.G., Yester, K.A., Romano, L.C., O'Doherty, R.M., McTiernan, C.F., et al. 2011. Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice. Cardiovasc. Res. 89: 60-71. doi:10.1093/cvr/cvq288. PMID:20833647.
37. Moey, M., Rajapurohitam, V., Zeidan, A., and Karmazyn, M. 2011. Ginseng (Panax quinquefolius) attenuates leptin-induced cardiac hypertrophy through inhibition of p115Rho guanine nucleotide exchange factor-RhoA/Rho-associated, coiled-coil containing protein kinase-dependent mitogen-activated protein kinase pathway activation. J. Pharmacol. Exp. Ther. 339: 746-756. doi:10.1124/jpet.111.182600. PMID:21875949.
38. Moro, C., Grauzam, S., Ormezzano, O., Toufektsian, M.C., Tanguy, S., Calabrese, P., et al. 2011. Inhibition of cardiac leptin expression after infarction reduces subsequent dysfunction. J. Cell. Mol. Med. 15: 1688-1694. doi:10. 1111/j.1582-4934.2010.01154.x. PMID:20731748.
39. Murdoch, D.R., Rooney, E., Dargie, H.J., Shapiro, D., Morton, J.J., and McMurray, J.J. 1999. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure. Heart, 82: 352-356. doi:10. 1136/hrt.82.3.352. PMID:10455089.
40. Myers, M.G., Jr. 2004. Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog. Horm. Res. 59: 287-304. PMID:14749507.
41. Nakamura, Y., Shimada, K., Fukuda, D., Shimada, Y., Ehara, S., Hirose, M., et al. 2004. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart, 90: 528-533. doi:10.1136/hrt.2003.011114. PMID:15084551.
42. Noma, K., Oyama, N., and Liao, J.K. 2006. Physiological role of ROCKs in the cardiovascular system. Am. J. Physiol. Cell Physiol. 290: C661-C668. doi:10. 1152/ajpcell.00459.2005. PMID:16469861.
43. Northcott, J.M., Yeganeh, A., Taylor, C.G., Zahradka, P., and Wigle, J.T. 2012. Adipokines and the cardiovascular system: mechanisms mediating health and disease. Can. J. Physiol. Pharmacol. 90(8): 1029-1059. doi:10.1139/y2012-053. PMID:22646022.
44. Ouchi, N., Kihara, S., Funahashi, T., Matsuzawa, Y., and Walsh, K. 2003. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 14: 561-566. doi:10.1097/00041433-200312000-00003. PMID:14624132.
45. Park, M., and Sweeney, G. 2012. Direct effects of adipokines on the heart: focus on adiponectin. Heart Fail. In press. doi:10.1007/s10741-012-9337-8. PMID: 22893246.
46. Patel, J.V., Sosin, M., Lim, H.S., Chung, I., Panja, N., Davis, R.C., et al. 2007. Raised leptin concentrations among South Asian patients with chronic heart failure. Int. J. Cardiol. 122: 34-40. doi:10.1016/j.ijcard.2006.11.013. PMID:17187880.
47. Peters, T., Ausmeier, K., and Ruther, U. 1999. Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation. Mamm. Genome, 10: 983-986. doi:10.1007/s003359901144. PMID:10501967.
48. Purdham, D.M., Zou, M.X., Rajapurohitam, V., and Karmazyn, M. 2004. Rat heart is a site of leptin production and action. Am. J. Physiol. Heart Circ. Physiol. 287: H2877-H2884. doi:10.1152/ajpheart.00499.2004. PMID:15284063.
49. Purdham, D.M., Rajapurohitam, V., Zeidan, A., Huang, C., Gross, G.J., and Karmazyn, M. 2008. A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart. Am. J. Physiol. Heart Circ. Physiol. 295: H441-H446. doi:10.1152/ajpheart.91537. 2007. PMID:18469142.
50. Rajapurohitam, V., Gan, X.T., Kirshenbaum, L.A., and Karmazyn, M. 2003. The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ. Res. 93: 277-279. doi:10.1161/01.RES.0000089255. 37804.72. PMID:12893740.
51. Rajapurohitam, V., Javadov, S., Purdham, D.M., Kirshenbaum, L.A., and Karmazyn, M. 2006. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. J. Mol. Cell. Cardiol. 41: 265-274. doi:10.1016/j.yjmcc.2006.05.001. PMID:16806260.
52. Rajapurohitam, V., Kilic, A., Javadov, S., and Karmazyn, M. 2012a. Role of NF-κB and p38 MAPK activation in mediating angiotensin II and endothelin-1-induced stimulation in leptin production and cardiomyocyte hypertrophy. Mol. Cell. Biochem. 366: 287-297. doi:10.1007/s11010-012-1307-x. PMID: 22527934.
53. Rajapurohitam, V., Izaddoustdar, F., Martinez-Abundis, E., and Karmazyn, M. 2012b. Leptin-induced cardiomyocyte hypertrophy reveals both calciumdependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation. Cell. Signal. 24: 2283-2290. doi:10.1016/j.cellsig.2012.07.025. PMID:22917533.
54. Rohini, A., Agrawal, N., Koyani, C.N., and Singh, R. 2010. Molecular targets and regulators of cardiac hypertrophy. Pharmacol. Res. 61: 269-280. doi:10.1016/j.phrs.2009.11.012. PMID:19969085.
55. Rondinone, C.M. 2006. Adipocyte-derived hormones, cytokines, and mediators. Endocrine, 29: 81-90. doi:10.1385/ENDO:29:1:81. PMID:16622295.
56. Sattar, N., Wannamethee, G., Sarwar, N., Tchernova, J., Cherry, L., Wallace, A.M., et al. 2006. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation, 114: 623-629. doi:10.1161/CIRCULATIONAHA.106. 618918. PMID:16894037.
57. Schram, K., Wong, M.M., Palanivel, R., No, E.K., Dixon, I.M., and Sweeney, G. 2008. Increased expression and cell surface localization of MT1-MMP plays a role in stimulation of MMP-2 activity by leptin in neonatal rat cardiac myofibroblasts. J. Mol. Cell. Cardiol. 44: 874-878. doi:10.1016/j.yjmcc.2008.03.005. PMID:18436234.
58. Schulze, P.C., and Kratzsch, J. 2005. Leptin as a new diagnostic tool in chronic heart failure. Clin. Chim. Acta, 362: 1-11. doi:10.1016/j.cccn.2005.05.019. PMID:16005450.
59. Schulze, P.C., Kratzsch, J., Linke, A., Schoene, N., Adams, V., Gielen, S., et al. 2003. Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur. J. Heart Fail. 5: 33-40. doi:10.1016/S1388-9842(02)00177-0. PMID:12559213.
60. Schulze, P.C., Biolo, A., Gopal, D., Shahzad, K., Balog, J., Fish, M., et al. 2011. Dynamics in insulin resistance and plasma levels of adipokines in patients with acute decompensated and chronic stable heart failure. J. Card. Fail. 17: 1004-1011. doi:10.1016/j.cardfail.2011.08.010. PMID:22123363.
61. Scuteri, A., Sanna, S., Chen, W.M., Uda, M., Albai, G., Strait, J., et al. 2007. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 3: e115. doi:10.1371/journal. pgen.0030115. PMID:17658951.
62. Sinha, M.K., Opentanova, I., Ohannesian, J.P., Kolaczynski, J.W., Heiman, M.L., Hale, J., et al. 1996. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J. Clin. Invest. 98: 1277-1282. doi:10.1172/JCI118913. PMID:8823291.
63. Straburzyńska-Migaj, E., Gwizdała, A., Siniawski, A., Ochotny, R., and Grajek, S. 2010. Leptin and inflammation in patients with chronic heart failure. Kardiol. Pol. 68: 1243-1247. PMID:21108202.
64. Tajmir, P., Ceddia, R.B., Li, R.K., Coe, I.R., and Sweeney, G. 2004. Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase-and phosphatidylinositol 3-kinase-dependent signaling pathways. Endocrinology, 145: 1550-1555. doi:10.1210/en.2003-1128. PMID:14715711.
65. Takano, H., Obata, J.E., Kodama, Y., Kitta, Y., Nakamura, T., Mende, A., et al. 2009. Adiponectin is released from the heart in patients with heart failure. Int. J. Cardiol. 132: 221-226. doi:10.1016/j.ijcard.2007.11.040. PMID:18192035.
66. Toth, M.J., Gottlieb, S.S., Fisher, M.L., Ryan, A.S., Nicklas, B.J., and Poehlman, E.T. 1997. Plasma leptin concentrations and energy expenditure in heart failure patients. Metabolism, 46: 450-453. doi:10.1016/S0026-0495(97)90065-2. PMID: 9109853.
67. Tung, Y.C., and Yeo, G.S. 2011. From GWAS to biology: lessons from FTO. Ann. N.Y. Acad. Sci. 1220: 162-171. doi:10.1111/j.1749-6632.2010.05903.x. PMID: 21388413.
68. Villanueva, E.C., and Myers, M.G., Jr. 2008. Leptin receptor signaling and the regulation of mammalian physiology. Int. J. Obes. (Lond.), 32(Suppl. 7): S8-S12. doi:10.1038/ijo.2008.232. PMID:19136996.
69. Wang, P., Yang, F.J., Du, H., Guan, Y.F., Xu, T.Y., Xu, X.W., et al. 2011. Involvement of leptin receptor long isoform (LepRb)-STAT3 signaling pathway in brain fat mass-and obesity-associated (FTO) downregulation during energy restriction. Mol. Med. 17: 523-532. doi:10.2119/molmed.2010.00134. PMID:21267512.
70. Wannamethee, S.G., Shaper, A.G., Whincup, P.H., Lennon, L., and Sattar, N. 2011. Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: does leptin have a role? J. Am. Coll. Cardiol. 58: 1870-1877. doi:10.1016/j.jacc.2011.06.057. PMID:22018297.
71. Wold, L.E., Relling, D.P., Duan, J., Norby, F.L., and Ren, J. 2002. Abrogated leptininduced cardiac contractile response in ventricular myocytes under spontaneous hypertension: role of Jak/STAT pathway. Hypertension, 39: 69-74. doi:10.1161/hy0102.100777. PMID:11799081.
72. Xu, F.P., Chen, M.S., Wang, Y.Z., Yi, Q., Lin, S.B., Chen, A.F., et al. 2004. Leptin induces hypertrophy via endothelin-1-1reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation, 110: 1269-1275. doi:10. 1161/01.CIR.0000140766.52771.6D. PMID:15313952.
73. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., et al. 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423: 762-769. doi:10.1038/nature01705. PMID:12802337.
74. Yanavitski, M., and Givertz, M.M. 2011. Novel biomarkers in acute heart failure. Curr. Heart Fail. Rep. 8: 206-211. doi:10.1007/s11897-011-0065-5. PMID: 21681444.
75. Zabeau, L., Lavens, D., Peelman, F., Eyckerman, S., Vandekerckhove, J., and Tavernier, J. 2003. The ins and outs of leptin receptor activation. FEBS Lett. 546: 45-50. doi:10.1016/S0014-5793(03)00440-X. PMID:12829235.
76. Zeidan, A., Javadov, S., and Karmazyn, M. 2006. Essential role of Rho/ROCKdependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes. Cardiovasc. Res. 72: 101-111. doi:10.1016/j.cardiores.2006.06.024. PMID:16901475.
77. Zeidan, A., Javadov, S., Chakrabarti, S., and Karmazyn, M. 2008. Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCKdependent p38 MAPK translocation to nuclei. Cardiovasc. Res. 77: 64-72. doi:10.1093/cvr/cvm020. PMID:18006472.
78. Zeidan, A., Hunter, J.C., Javadov, S., and Karmazyn, M. 2011. mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy. Mol. Cell. Biochem. 352: 99-108. doi:10.1007/s11010-011-0744-2. PMID:21318349.
79. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J.M. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature, 372: 425-432. doi:10.1038/372425a0. PMID:7984236.
80. Zibadi, S., Cordova, F., Slack, E.H., Watson, R.R., and Larson, DF. 2011. Leptin's regulation of obesity-induced cardiac extracellular matrix remodeling. Cardiovasc. Toxicol. 11: 325-333. doi:10.1007/s12012-011-9124-0. PMID:21744298.